A 48 Week Phase II, Randomized, Open-Label, Multicenter, Study to Evaluate the Efficacy and Safety of Two (2) EYS606 (pEYS606 administered by injection and electrotransfer to the ciliary muscle) Treatment Regimens in Patients with CNIU
Research Grant
Administered By
Ophthalmology
Awarded By
Eyevensys
Start Date
September 18, 2019
End Date
December 31, 2021
Administered By
Ophthalmology
Awarded By
Eyevensys
Start Date
September 18, 2019
End Date
December 31, 2021